These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32368535)

  • 1. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
    Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
    World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
    Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
    BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection.
    Peng J; Li C; Wang F; Zhang H; Xiao W; Li H; Lu Z; Pan Z; Wu X; Zhang R
    Cancer Manag Res; 2018; 10():2095-2103. PubMed ID: 30140160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
    Azar I; Al Masalmeh N; Esfandiarifard S; Virk G; Kiwan W; Frank Shields A; Mehdi S; Philip PA
    Cancer Med; 2021 May; 10(9):2987-2995. PubMed ID: 33797856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis.
    Li D; Fu Q; Li M; Li J; Yin C; Zhao J; Li F
    Future Oncol; 2017 May; 13(12):1115-1127. PubMed ID: 28110551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China.
    Abasse Kassim S; Tang W; Abbas M; Wu S; Meng Q; Zhang C; Li X; Chen R
    Cancer Epidemiol; 2019 Oct; 62():101565. PubMed ID: 31323459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
    Lim DR; Kuk JK; Kim T; Shin EJ
    Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
    Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
    Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study.
    Grassadonia A; Di Marino P; Ficorella C; Cortellini A; Cannita K; Parisi A; Gamucci T; Zoratto F; Vici P; Barba M; Porreca E; Neri M; Veronese A; Natoli C; De Tursi M; Tinari N
    J Cancer; 2019; 10(24):5926-5934. PubMed ID: 31762802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer.
    Narayanan S; Gabriel E; Attwood K; Boland P; Nurkin S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e671-e678. PubMed ID: 30108021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study.
    Beltrán L; González-Trejo S; Carmona-Herrera DD; Carrillo JF; Herrera-Goepfert R; Aiello-Crocifoglio V; Gallardo-Rincón D; Meléndez-Ponce NA; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Arch Med Res; 2019 Feb; 50(2):63-70. PubMed ID: 31349955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
    An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
    Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
    Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
    Jiang Y; Yan X; Liu K; Shi Y; Wang C; Hu J; Li Y; Wu Q; Xiang M; Zhao R
    BMC Cancer; 2020 Oct; 20(1):1012. PubMed ID: 33076847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.
    Wang QY; Zhong WT; Xiao Y; Lin GL; Lu JY; Xu L; Zhang GN; Du JF; Wu B
    World J Gastroenterol; 2024 Sep; 30(33):3823-3836. PubMed ID: 39351432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of tumour sidedness in patients with stage II colon cancer: a single-centre retrospective study.
    Iguchi K; Mushiake H; Fukushima T; Rino Y; Masuda M
    ANZ J Surg; 2021 Apr; 91(4):E196-E202. PubMed ID: 33559326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of primary colorectal Cancer location on the KRAS status and its prognostic value.
    Xie MZ; Li JL; Cai ZM; Li KZ; Hu BL
    BMC Gastroenterol; 2019 Mar; 19(1):46. PubMed ID: 30917791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.